Baljit Singh

Active 1992–2025

182
Papers
21,088
Citations
77
h-index
161
i10-index

Citations

Citations per year for Baljit Singh1971: 1 citations1993: 1 citations1996: 4 citations1997: 3 citations1998: 2 citations1999: 10 citations2000: 8 citations2001: 22 citations2002: 58 citations2003: 127 citations2004: 125 citations2005: 138 citations2006: 152 citations2007: 101 citations2008: 110 citations2009: 122 citations2010: 90 citations2011: 115 citations2012: 124 citations2013: 119 citations2014: 131 citations2015: 144 citations2016: 162 citations2017: 183 citations2018: 190 citations2019: 603 citations2020: 781 citations2021: 764 citations2022: 579 citations2023: 419 citations2024: 722 citations2025: 378 citations2026: 14 citations1972–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,008 citing papers, 20.5% of this breakdownChina: 901 citing papers, 9.2% of this breakdownUnited Kingdom: 613 citing papers, 6.3% of this breakdownIndia: 532 citing papers, 5.4% of this breakdownItaly: 472 citing papers, 4.8% of this breakdownGermany: 429 citing papers, 4.4% of this breakdownFrance: 320 citing papers, 3.3% of this breakdownSpain: 306 citing papers, 3.1% of this breakdownCanada: 301 citing papers, 3.1% of this breakdownJapan: 250 citing papers, 2.6% of this breakdownAustralia: 231 citing papers, 2.4% of this breakdownNetherlands: 230 citing papers, 2.3% of this breakdown
0%20.5%Other 32.6%

Fields

  • Medicine34.7%
  • Biochemistry, Genetics and Molecular Biology30.5%
  • Immunology and Microbiology8.7%
  • Nursing6.7%
  • Environmental Science4.2%
  • Agricultural and Biological Sciences4.2%
  • Other11%

Topics

  • Breast Cancer Treatment Studies5.2%
  • Cancer Immunotherapy and Biomarkers3.7%
  • HER2/EGFR in Cancer Research3%
  • Food composition and properties2.8%
  • Immune Cell Function and Interaction2.3%
  • Immunotherapy and Immune Responses2.1%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  2. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 720

  3. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,030

  4. CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William M. Sikov - Journal of Clinical Oncology 2022 cited by 151

  5. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Seminars in Cancer Biology 2017 cited by 432

  6. Effect of thermal processing on the bioactive compounds, antioxidative, antinutritional and functional characteristics of quinoa (Chenopodium quinoa)

    Authors: , , - LWT 2022 cited by 119

  7. Nanotechnology-based drug delivery systems

    Authors: , , - Journal of Occupational Medicine and Toxicology 2007 cited by 746

  8. Millets as potential nutri‐cereals: a review of nutrient composition, phytochemical profile and techno‐functionality

    Authors: , , , - International Journal of Food Science & Technology 2021 cited by 129

  9. Advanced glycation End-products (AGEs): an emerging concern for processed food industries

    Authors: , , , , - Journal of Food Science and Technology 2015 cited by 252

  10. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J. Schnitt, Sunil R. Lakhani, Federico Rojo, Laura Comerma, Sunil Badve, Mehrnoush Khojasteh, W. Fraser Symmans, Christos Sotiriou, Paula I. González-Ericsson, Katherine L. Pogue–Geile, Rim S. Kim, David L. Rimm, Giuseppe Viale, Stephen M. Hewitt, John M. S. Bartlett, Frédérique Penault–Llorca, Shom Goel, Huang‐Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G. Hanna, Stefan Michiels, Marleen Kok, Torsten O. Nielsen, Alexander J. Lazar, Zsuzsanna Bagó-Horváth, Loes Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D. Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee Cooper, International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair M. Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo, Anna Sapino, André L. Moreira, Andrea L. Richardson, Andrea Vingiani, Andrew M. Bellizzi, Andrew Tutt, Ángel Guerrero‐Zotano, Anita Grigoriadis, Anna Ehinger, Ana C. Garrido-Castro, Anne Vincent-Salomon, Anne‐Vibeke Lænkholm, Ashley Cimino‐Mathews, Ashok Srinivasan, Balázs Ács, Baljit Singh, Benjamin C. Calhoun, Benjamin Haibe-Kans, Benjamin Solomon, Bibhusal Thapa, Brad H. Nelson, Carlos Castaneda, Carmen Ballesteroes-Merino, Carmen Criscitiello, Carolien Boeckx and 158 more - npj Breast Cancer 2020 cited by 166

  11. Electrochemical Biosensors for Detection of Pesticides and Heavy Metal Toxicants in Water: Recent Trends and Progress

    Authors: , - ACS ES&T Water 2021 cited by 242

  12. Effect of germination time and temperature on the functionality and protein solubility of sorghum flour

    Authors: , , - Journal of Cereal Science 2017 cited by 188

  13. Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 cited by 75

  14. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

    Authors: , , , , , , , - The Journal of Experimental Medicine 2011 cited by 624

  15. On the Detection of Kernel-Level Rootkits Using Hardware Performance Counters

    Authors: , , , , - on Asia Conference on Computer and Communications Security, AsiaCCS 2017 cited by 109

  16. Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 437

  17. Nanomaterials‐Based Biosensors for the Detection of Prostate Cancer Biomarkers: Recent Trends and Future Perspective

    Authors: , , , - Advanced Materials Technologies 2023 cited by 45

  18. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph T. Rabban, Yunni-Yi Chen, Dilip D. Giri, Alfred Au, Nola M. Hylton - Breast Cancer Research and Treatment 2011 cited by 376

  19. Influence of polymer network parameters of tragacanth gum-based pH responsive hydrogels on drug delivery

    Authors: , - Carbohydrate Polymers 2013 cited by 175

  20. Electrochemical Biosensors for the Detection of Antibiotics in Milk: Recent Trends and Future Perspectives

    Authors: , , , , , - Biosensors 2023 cited by 54

  21. Antioxidant activity of barley as affected by extrusion cooking

    Authors: , , - Food Chemistry 2011 cited by 245

  22. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - npj Breast Cancer 2016 cited by 114

  23. Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 441

  24. Breast cancer molecular subtypes: from TNBC to QNBC.

    Authors: , , , , , , , , , - 2016 cited by 184